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1078–5884/00Conversion to Open Repair After Endografting for Abdominal
Aortic Aneurysm: Causes, Incidence and Results
F. Verzini, P. Cao,* P. De Rango, G. Parlani, D. Xanthopoulos,
G. Iacono and G. PanuccioDepartment of Vascular Surgery, University of Perugia, Azienda Ospedaliera di Perugia, Perugia, ItalyObjective. To evaluate frequency, causes and results of conversion to Open repair (OR) after endovascular repair (EVAR) in
a single centre during an 8-year period.
Design. Six hundred and forty-nine consecutive patients undergoing EVAR were followed up prospectively for endograft-
related complications.
Outcomes. Early conversion was any OR during or within 30 days from the primary EVAR. Late conversion was any OR
with removal of the endograft after 30 days since a completed EVAR procedure.
Results. Median patient follow-up was 38 months (1–93 months). Conversion to OR was performed in 38 patients; nine
early and 29 late. Most (7/9) early conversions were due to extensive vessel calcification. Peri-operative mortality was 22%
(2/9). Late conversions occurred at a median of 33 months after primary EVAR: 29 were elective and 4 urgent. During the
same interval, 79 secondary endovascular interventions were performed, 7 of which failed. The risk of conversion to OR was
9% at 6 years. At multivariate logistic regression analysis, no single factor (short, large or angulated neck, suprarenal
fixation, large pre-operative diameter, iliac aneurysms, ASA score risk) was associated with the risk of late failure requiring
conversion to OR.
Conclusion. The risk of death after early conversion should be recognized, to avoid forcing morphological indications for
primary EVAR. Occurrence of late conversion after EVAR is not negligible, affecting almost 1 out of 10 patients after 6 years.
In the presence of an expanding aneurysm after EVAR, especially after a failed secondary endovascular correction, an
aggressive attitude in fit patients allows outcomes at similar to those of primary OR.Keywords: Conversion; Abdominal aortic aneurysm; Endovascular repair; Open repair.Introduction
Recently published trials comparing endoluminal
repair of abdominal aortic aneurysm (EVAR) versus
open surgery have shown no differences in overall
survival rates, although a lower risk of aneurysm-
related death at a cost of a higher reintervention rate
has been reported.1,2 These data confirm the results of
monocentric non-randomised series in which the
advantage of EVAR over open repair (OR) was
maintained at least 7 years, even though the risk of
reintervention was about 50% for longest available
follow-up.3,4 Usually, most EVAR complications even-
tually leading to aneurysm rupture, such as migration,
endoleak and structural graft failures, can be treated
with adjunctive endovascular procedures and rarelying author. Prof Piergiorgio Cao, MD, FRCS, Chief of
gery, University of Perugia, Azienda Ospedaliera di
Brunamonti, Perugia 06122, Italy.
: pcao@unipg.it
0136 + 07 $35.00/0 q 2006 Elsevier Ltd. All rights reserrequire conversion to OR.5–8 Open surgery under such
circumstances is usually considered more risky than
the primary operation, due to the presence of the
endograft in the operating field and the urgent
condition.9 Initial experiences showed high mortality
and morbidity rates mainly associated with immediate
conversions performed during the course of the
primary planned EVAR procedure.9 The aim of this
study is to evaluate frequency, causes and results of all
conversions to OR after EVAR in our series of 649
consecutive patients treated during an 8-year period.
Predictive factors of late conversion also were
investigated.Material and Methods
Between April 1997 and March 2005, a total of 1303
consecutive patients with AAA underwent elective
repair in our department: 654 (50.2%) with OR and 649Eur J Vasc Endovasc Surg 31, 136–142 (2006)
doi:10.1016/j.ejvs.2005.09.016, available online at http://www.sciencedirect.com onved.
Table 1. Demographic data and risk factors on 38 patients
converted to open repair
%
Median age (years) 72
Gender (male) 33 87
Smoking 27 71
Hypertension 23 61
Diabetes 1 3
Cardiac disease 14 37
Respiratory disease 18 47
Renal insufficiency 5 13
ASA class (III or IV) 29 76
Conversion After Endovascular Repair of Aortic Aneurysm 137(49.8%) with EVAR. The indications for EVAR versus
OR have been described in a previous report.3
A wide variety of endografts were used: the
AneuRx stent graft (Medtronic, Santa Rosa, CA,
USA) was implanted in 238 procedures, the Zenith
graft (William Cook Europe, Biaeverskow, Denmark)
in 181, the Talent graft (World Medical-Medtronic,
Sunrise, FL, USA) in 98, the Excluder (WL Gore and
Associates, Flagstaff, AZ, USA) in 81, the Fortron
(Cordis, Warren, NJ, USA) in 36, the Anaconda in 11
(Sulzer Vascutek, Edinburgh, UK), the Endologix
(Bard, Irvine, CA) in 3, and the Endofit (Endomed,
Phoenix, AZ, USA) in 1. Endograft configuration
included 4 tubes, 624 bifurcated grafts, and 21 aorto-
uniliac grafts.
Follow-up schedule consisted of physical exam-
ination, color duplex scan and plain abdominal
X-ray repeated at 1, 6, 12 months after the
procedure and every 6 months thereafter. Contrast-
enhanced CT scan was performed 1 month after
surgery and then annually. All data were collected
prospectively in a database. Median follow-up was
38 months (range 1–93 months). Three patients
refused regular imaging follow-up after the first-
year.
Early conversion was considered as any open AAA
repair during or within 30 days from the primary
endovascular operation. Late conversion was con-
sidered as any OR with removal of the entire
endograft, or at least the main body of the endograft,
occurring anytime 30 days after a completed EVAR
procedure.
Indications for late conversions were: AAA
growthO5 mm with or without endoleak, late onset
of high flow type I or III endoleak with or without
aneurysm growth, loss of contact between the
endograft and the aortic neck due to graft migration
or neck dilation and AAA rupture. Type II endoleaks
were observed, without treatment, when these were
not associated with AAA diameter increase. In cases of
AAA growth, conversion to OR was offered to patients
fit for surgery, whereas a lumbar CT guided percuta-
neous puncture with embolization of the aneurysmal
sac was offered to higher risk patients with type II
endoleak.
In the presence of complications indicative of EVAR
failure, from CT examination, the indication for
conversion was established after evaluation of the
feasibility of a secondary endovascular procedure and
according to patient choice when fit for open surgery.
In all cases a complete risk/benefit assessment was
performed for each patient.Statistical analysis
For risk factors and pre-operative findings statistical
significance was assessed using two-tailed c2 test with
Yates correction or Fisher exact test. For each outcome
either an odds ratio (OR) or hazard ratio (HR) with
95% confidence intervals (95% CI) were calculated by
standard methods. Continuous variables were dis-
played as median values and ranges. Risk of late
conversion was calculated by life table analysis
(Kaplan–Meier method with log-rank test). To identify
potential predicting factors of late conversion, multi-
variate analyses with conditional logistic-regression
models were used. Variables chosen for inclusion in
this model were age, female gender, AAA diameter,
proximal neck diameter, neck length, neck angulation,
extensive iliac aneurysmal involvement (Eurostar
class D or E), ASA score and infrarenal fixation.
Significance was at the 5% level. Statistical package
Software SPSS (SPSS Inc., Chicago, IL, USA) was used
for analysis.Results
Of 649 patients who underwent EVAR, successful graft
deployment was achieved in 640 patients (98.6%).
Conversion to OR was performed in 38 patients.
Immediate conversion was required in nine patients
(1.4%), while 29 patients (4.5%) required late OR
during a median follow-up of 38 months.
Median age of 38 patients undergoing conversion to
OR was 72.2 years (range 55–85 years). Demographic
data and risk factors for all conversions are shown in
Table 1.Early conversion
Early conversions occurred at all stages of the primary
operation, in eight males and one female with a
median age of 76 years (range 71–81 years).Eur J Vasc Endovasc Surg Vol 31, 2 2006
F. Verzini et al.138The endograft removed was the AneuRx device in six
cases and Talent in the remaining three.
Causes for early conversion were:
(1) extensive vessel calcification (NZ7) leading to
proximal graft migration during deployment,
mechanical deployment failure or impossibility
of device progression,
(2) aortic neck rupture (NZ1),
(3) failed catheterisation of the contralateral limb
(NZ1).
All early conversions were carried out with a
midline trans-peritoneal approach. In seven patients
aortic cross-clamping below the renal arteries was
used, one patient required supra-renal clamping and
another patient supra-celiac clamping. A tube graft
was placed in seven cases. In one patient an aorto-Table 2. Details and causes of late conversion to open repair in 29 pa
Case N AAA pre-oper-
ative diameter
(mm)
AAA diam-
eter at con-
version (mm)
Type of
device
Seconda
procedu
before O
1 44 44 AneuRx No
2 51 52 AneuRx No
3 52 57 AneuRx Prox cu
4 51 42 Anaconda No
5 72 81 AneuRx No
6 55 55 Talent Iliac cuf
7 45 60 AneuRx Prox cu
8 78 80 AneuRx No
9 46 46 Anaconda No
10 40 35 AneuRx No
11 50 48 Anaconda No
12 60 65 Excluder No
13 50 59 AneuRx Prox cu
14 70 80 Excluder No
15 42 38 AneuRx No
16 45 49 AneuRx No
17 52 46 Anaconda No
18 77 85 AneuRx No
19 77 88 Talent No
20 70 92 Aneurx No
21 43 56 Aneurx No
22 50 58 Talent No
23 48 53 Aneurx No
24 73 100 Talent No
25 46 45 Endologix No
26 40 53 AneuRx No
27 52 46 AneuRx No
28 52 84 AneuRx No
29 50 57 Aneurx Prox cu
AND= aortic neck dilatation; Migr= distal migration; Type I–III= type
Eur J Vasc Endovasc Surg Vol 31, 2 2006femoral by-pass was needed for iliac dissection,
secondary to the endovascular attempts; the remain-
ing patient had a bifurcated graft to the iliac arteries.
Median blood loss was 1837 ml (range 1000–3500 ml,
excluding the aortic rupture case where blood loss
was 10,000 mlc). All patients were transferred to
intensive care unit, with a median stay of 20 h
(range 6–24 h).
Two patients died peri-operatively (22%), one for
multiple organ failure after massive bleeding
secondary to aortic rupture and the other for
myocardial infarction after reoperation for acute limb
ischemia. Three non-fatal major complications
occurred (33%), one myocardial infarction, one
abdominal wall dehiscence requiring re-operation
and prolonged hospitalisation, and one post-operative
bleeding requiring surgical exploration. Median post-
operative hospital stay was 12 days (range 5–27 days).tients
ry
re
R
Elapsed time
from EVAR to
OR (months)
Indications for conver-
sions
Intraopera-
tive findings
23 MigrCANDCsecond-
ary type I
Confirmed
16 MigrCANDCsecond-
ary type ICback pain
Confirmed
ff 27 ANDCtype IICAAA
growth
Confirmed
6 ANDCMigrCKinking Confirmed
23 AAA growth Hygroma
f 22 Type III Microleak
ff 41 AAA ruptureCsecond-
ary type III
Confirmed
30 AAA growthCtype II Confirmed
13 MigrCAND Confirmed
45 MigrCsecondary type I Confirmed
16 MigrCAND Confirmed
32 AAA growthCtype II Confirmed
ff 46 AAA growthCsecond-
ary type III
Confirmed
23 AAA growth Hygroma
38 Migr Confirmed
43 AAA growthCAND Confirmed
23 ANDCMigr Confirmed
32 AAA growth Microleak
33 AAA growth Microleak
56 AAA ruptureCtype I Confirmed
27 ANDCMigrCAAA
growth
Confirmed
46 ANDCAAA growth Confirmed
75 AAA growthCMigr Confirmed
32 AAA ruptureCAAA
growthCANDC
MigrCsecondary type I
Confirmed
26 MigrCtype I Confirmed
74 ANDCAAA growth Confirmed
73 ANDCMigr Confirmed
62 AAA growthCANDC
MigrCseondary type I
Confirmed
ff 82 AAA growthCtype III ConfirmedC
fabric tear
of endoloeak.
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Late conversions were necessary in 29 patients. Details
and causes are indicated in Table 2. During the same
interval 79 patients underwent one or more secondary
endovascular reinterventions for EVAR complications.
In 72 patients, the secondary procedures were
accomplished successfully, with benefit persisting in
the long-term. The remaining seven patients required
late conversion to OR. Median interval from primary
endovascular procedure to secondary OR was 33
months (range 7–85 months). Median AAA diameter
at the time of endografting for these patients was
52 mm (range 40–78 mm), while median aortic diam-
eter at the time of conversion was 60 mm (range
35–100 mm).
Four of the 29 patients required urgent surgery for
rupture (NZ3) or acute occurrence (NZ1) of second-
ary type I endoleak leading to impending rupture. Of
the three patients treated for rupture, one had
previously refused a planned secondary intervention
for migration of the proximal graft, another did not
comply with the imaging follow-up protocol and after
3 years presented a ruptured AAA secondary to graft
migration, the third patient experienced acute type III
endoleak for disconnection between the proximal cuff
and the main body of the graft.
Of the entire cohort of 649 EVAR, three other
patients presented with ruptured aneurysm at other
hospitals, where they did not undergo any surgical
treatment. These three patients were not included in
the present cohort of 29 late conversions. Overall, there
were six ruptures during EVAR follow-up.
The remaining 25 late conversions were elective. A
variety of endografts were explanted: 18 AneuRx, 4
Anaconda, 4 Talent, 2 Gore e 1 Endologix (Table 2).
Four of these conversions were carried out in other
hospitals and the retrieved data were cumulated in the
same database.Table 3. Risk factors in 634 patients with and without late conversio
Conversion
Yes (NZ29) No (NZ605)
Gender (female) 4 (14%) 36
Age (R80 years) 2 94
ASA IV score 0 111
Proximal neck length
%15 mm
3 (%) 61 (%)
Proximal neck
diameter R26 mm
2 (%) 66 (%)
Neck angulation O608 4 (%) 22 (%)
AAA diameter
R55 mm
9 (%) 200 (%)
Infrararenal fixation 25 (%) 479 (%)
EUROSTAR class D/E 2 (%) 164 (%)Surgical access was obtained in 24 cases through a
midline trans-peritoneal approach and in five with a
left retro-peritoneal incision. Intra-operative findings
did not confirm the pre-operative indication in six
patients who presented growing AAA due to causes
(three microleaks, one fabric tear and two hygromas)
different from those suspected, or not detected at the
pre-operative CT scan. The other causes of graft failure
were accurately detected by pre-operative imaging
(Table 2). Only one out of three patients with microleak
was on anticoagulant therapy (for atrial fibrillation).
Aortic cross-clamping was suprarenal in 12 cases
and infrarenal in the remaining 16 cases. Complete
removal of the endograft was possible in all but two
cases. In one patient the supra-renal stent of the Talent
graft was left in place, using a wire cutter to remove
the covered portion of the endograft, while in the
other an AneuRx iliac extension was not removed.
Aorto-iliac reconstruction was performed in 23
patients; aorto-femoral in four, aorto-aortic in one.
Median intra-operative estimated blood loss was
2200 ml (range 100–7000 ml); 18 patients required
blood transfusion (median 3 units, range 1–8 units).
Median intensive care stay was 24 h (0–72 h). Post-
operative median hospital stay was 6 days (4–7 days).
There was no mortality at 30 days either in elective or
in urgent surgery for late conversion. The major
morbidity rate (non-fatal) was 20.7%, with two cases
of pneumonia, one case of atrial fibrillation, one case of
worsening renal failure and one post-operative
bleeding requiring transfusion.
Risk of conversion during follow-up is shown in
Fig. 1, the risk of late conversion after EVAR was 9% at
6 years (Kaplan–Meier estimate). After this point, there
were too few patients to allow meaningful evaluation.
Median follow-up after conversion was 27 months
(range 1–60 months). Two patients died of causes
unrelated to their AAA, one from stroke at 3 months
and one from myocardial infarction at 27 months aftern (Univariate analysis)
OR 95% CI p
0.4 0.13–1.2 0.10
0.4 0.09–1.7 0.29
– – 0.005
0.9 0.29–3.3 1
0.6 0.14–2.6 0.76
4.2 1.35–13.2 0.03
0.9 0.41–2.0 1
1.6 0.56–4.8 0.5
0.2 0.04–0.84 0.02
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Fig. 1. Conversion rate after EVAR in 649 patient (Kaplan–
Meier).
F. Verzini et al.140conversion. One case of inguinal infection requiring
femoral limb graft in situ replacement occurred during
follow-up; no other late complications secondary to
OR occurred in any of the converted patients. Multi-
variate analysis failed to identify any factor associated
with late conversion. Risk factors in patients with and
without conversion are shown in (Table 3).Fig. 2. CT scan 82 months after EVAR showing type III
endoleak.Discussion
Our results confirm that early conversion after EVAR
is a rare event (1.4%) but carries a high operative risk
(22% peri-operative mortality rate) mainly due to the
length of the procedure and the possibility of
associated vascular injuries. The single and fatal case
of aortic rupture occurred at the bottom of a conical
angulated neck, during deployment of the endograft.
In all other patients, challenging iliac anatomy with
severe vessel calcifications was the primary cause of
unsuccessful deployment. These findings suggest that
patients should not be considered for EVAR when, at
the pre-operative CT imaging, the iliac arteries appear
to be severely calcified and angulated. Alternatively,
an iliac conduit may be used from the beginning of the
endovascular procedure to avoid iliac dissection or
rupture after repetitive forceful introduction of large
size introducer devices.
The rate of early conversion, with attendant
increase of operative risk, can be reduced with
technical improvements and better patient selection.
A thorough anatomical evaluation of the access vessels
as well as the aortic neck is crucial to ascertain patient
suitability for EVAR and avoid unsuccessful deploy-
ment. Obviously, less stringent anatomical criteriaEur J Vasc Endovasc Surg Vol 31, 2 2006may be used in elderly, high-risk patients with large
AAA. Under these circumstances the acceptable risk of
possible late endograft failure, manageable with a
secondary endovascular re-intervention, always
should be balanced against the risk of an unsuccessful
deployment highly harmful in this subset of patients.
Late conversions after EVAR were more frequent
(9% at 6 years, Kaplan–Meier estimate) but were not
associated with peri-operative mortality in the present
cohort. OR is believed to be a ‘hazardous procedure’
after a failed EVAR, as stated by May et al. who
reported a mortality rate as high as 17%.9 This
contrasts with our experience, where there was no
peri-operative mortality in the 29 patients undergoing
late OR.
Stringent patient follow-up after EVAR and accu-
rate analysis of any morphological or structural
change over the time may reduce the risk of acute
onset of complications with the following need of
urgent open conversion, to allow safer scheduling of
elective OR when needed. The incidence of late
conversion after EVAR is reported widely in the
literature, ranging from 4 to 50% and is dependent
on centre experience, type of graft used, length of
follow-up and compliance with follow-up protocols.1,
2,5,8–14 The EUROSTAR registry reported a cumulative
conversion risk of 2.1% per year, statistically associ-
ated with type I–III endoleak, graft migration and graft
kinking.14 This risk seems to be reduced with
contemporary results and grafts. In the recently
published EVAR 1 trial mid-term results, crude rate
of conversion to OR, at an average follow-up of 3.3
Conversion After Endovascular Repair of Aortic Aneurysm 141years, was 2.6%. Comparison with our results is
difficult because of differences in the length of
follow-up and methodology (in the EVAR 1 trial
conversion rate was measured as a crude rate, and the
follow-up was shorter).1
It is not surprising that, as in our cohort, the risk of
conversion from primary EVAR increases with time
(Fig. 1). For the same reason, most of the late
conversions involved the AneuRx endograft, since
this model was used predominantly in the early
experience at our centre and therefore contributed
heavily to long-term follow up and presumably
contributed most to the learning curve. Interestingly,
the patient with the oldest EVAR implant requiring
conversion had a sudden onset of type III endoleak at
82 months due to a large size fabric tear, as shown in
Figs. 2 and 3. This was the only case of clinically
relevant structural failure in our cohort other thanFig. 3. Explanted endograft showing lthree cases of microleak due to suture holes, probably
present since the time of implant. It also is noteworthy
that in 6 of 29 patients requiring conversion the causes
of graft failure were not identified pre-operatively and
unexpected findings were discovered intra-opera-
tively (Table 2).
The endovascular approach was routinely con-
sidered first-line treatment in late endograft failure.
However, in almost 10% (7/79) of cases, in spite of
early success of the secondary endovascular pro-
cedures, patients required conversion to OR later in
follow-up. Progressive AAA growth without signs of
morphological, structural or haemodynamic failure at
CT/ultrasound or X-ray imaging was interpreted as
the most reliable indicator of the need for conversion.
Consequently, when there is no evident cause for
aneurysm growth and the patient has an acceptable
surgical risk, elective surgical conversion is consideredarge size fabric tear in the left limb.
Eur J Vasc Endovasc Surg Vol 31, 2 2006
F. Verzini et al.142a valuable first option. It is possible that this
aggressive strategy, together with the increased
awareness of our EVAR patients and practitioners to
refer immediately any sudden onset of symptoms to
our centre, may have had a beneficial effect on
reducing the number of urgent cases requiring
conversion to OR.
Surprisingly, at multivariate analysis we could not
find any single factor associated with late failure. All
factors widely believed to influence adversely EVAR
outcome, such as AAA diameter, proximal neck
diameter, length or angulation, extensive iliac aneur-
ysmal involvement, infrarenal/suprarenal fixation
endograft, were not significantly associated with risk
of late conversion. Perhaps the decision for conversion
is the conclusion of a complex decision-making
process based on multiple co-existing adverse factors
occurring at different follow-up intervals.
In cases of AAA rupture, some authors report a
relatively low post-operative mortality and have
postulated that the presence of an endograft exerts
some protection and haematoma confinement. In
contrast, Bernhard et al. reported an overall mortality
rate of 50% following AAA rupture post-endografting
with the Guidant devices.15 Our three cases of
ruptured AAA underwent immediate CT scan,
followed by prompt conversion to OR, with a very
short delay from the onset of symptoms, had
straightforward infrarenal aortic cross-clamping and
experienced no major complications. Our absence of
mortality after ruptured AAA is potentially biased by
exclusion of the three fatalities in patients referred to
other hospitals, who died without undergoing oper-
ation. Perhaps those were the most critical patients
and intervention was denied because of their critical
condition, associated with the advanced age of the
patients (78, 80 and 83 years). If we included these
three patients with rupture who died without repair,
our mortality for ruptured AAA after endografting
would have risen to 50%.
In conclusion, early open conversion frequently is
due to severe vessel calcifications and has high peri-
operative mortality. Recognition of this should prevent
the endovascular specialist from forcing morphologi-
cal indications for primary EVAR. The risk of
conversion after abdominal aortic endografting is not
negligible, affecting almost one out of 10 patients
surviving 6 years. No single anatomical factor was
associated with an increased risk of late failure. These
data suggest that, at present, a more relaxed long-term
follow-up schedule after endoluminal repair cannot be
justified. In cases of aneurysm growth (without signs
of morphological, structural or haemodynamic failure)
either after primary EVAR or a subsequent failedEur J Vasc Endovasc Surg Vol 31, 2 2006endovascular reintervention, an aggressive attitude
for OR in patients fit for open surgery permits
adequate planning for conversion and yields to results
not inferior to those of primary open aneurysm repair.References
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